Risk factors and early detection of breast cancer: facts, questions, and genome-based perspectives.

1. Narod SA. Early-onset breast cancer: what do we know about the risk factors? A Countercurrents Series. Curr Oncol 2011;18:204–5. 2. Green ED, Guyer MS on behalf of National Human Genome Research Institute. Charting a course for genomic medicine from base pairs to bedside. Nature 2011;470:204–13. 3. Ruder WC, Lu T, Collins JJ. Synthetic biology moving into the clinic. Science 2011;333:1248–52. 4. Ziogas DE, Roukos DH. Genome diagnostics: next-generation sequencing, new genome-wide association studies and clinical challenges. Expert Rev Mol Diagn 2011;11:663–6. 5. Katsios C, Roukos DH. Individual genomes and personalized medicine: life diversity and complexity. Per Med 2010;7:347–50. 6. Roukos DH. Personal genomics and genome-wide association studies: novel discoveries but limitations for practical personalized medicine. Ann Surg Oncol 2009;16:772–3. 7. Roukos DH. Bionetworks-based personalized medicine versus comparative-effectiveness research or harmonization of both in cancer management? Expert Rev Mol Diagn 2010;10:247–50. 8. Roukos DH. Complete genome sequencing and network modeling to overcome trastuzumab resistance. Pharmacogenomics 2010;11:1039–43. 9. Roukos DH. Next-generation, genome sequencing-based biomarkers: concerns and challenges for medical practice. Biomark Med 2010;4:583–6. The Editor Current Oncology March 28, 2012